In two distinct cohorts of grade 1 and grade 2 meningiomas, we aimed to better clarify the prognostic role of Ki-67 and MCM6, and thus their potential usefulness in clinical practice within grade 1 or grade 2 tumors, in addition to the WHO grading system. The gene discussed is MCM6; the disease is meningioma.